Compare Astena Holdings Co., Ltd. with Similar Stocks
Dashboard
1
Weak Long Term Fundamental Strength with a 5.33% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 6.80% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of -0.83% and Operating profit at 5.33% over the last 5 years
3
Flat results in May 26
4
With ROCE of 7.65%, it has a very attractive valuation with a 0.82 Enterprise value to Capital Employed
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 21,209 Million (Small Cap)
8.00
NA
0.19%
0.41
8.30%
0.75
Revenue and Profits:
Net Sales:
18,009 Million
(Quarterly Results - May 2026)
Net Profit:
828 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.87%
0%
7.87%
6 Months
8.32%
0%
8.32%
1 Year
1.56%
0%
1.56%
2 Years
7.87%
0%
7.87%
3 Years
18.41%
0%
18.41%
4 Years
17.34%
0%
17.34%
5 Years
-5.62%
0%
-5.62%
Astena Holdings Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-0.83%
EBIT Growth (5y)
5.33%
EBIT to Interest (avg)
19.86
Debt to EBITDA (avg)
2.05
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
1.31
Tax Ratio
22.22%
Dividend Payout Ratio
33.19%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.92%
ROE (avg)
6.80%
Valuation key factors
Factor
Value
P/E Ratio
8
Industry P/E
Price to Book Value
0.72
EV to EBIT
10.66
EV to EBITDA
6.55
EV to Capital Employed
0.82
EV to Sales
0.51
PEG Ratio
0.72
Dividend Yield
0.20%
ROCE (Latest)
7.65%
ROE (Latest)
8.80%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - May'26 - QoQ
May'26
Nov'25
Change(%)
Net Sales
18,009.00
17,267.00
4.30%
Operating Profit (PBDIT) excl Other Income
1,902.00
880.00
116.14%
Interest
97.00
56.00
73.21%
Exceptional Items
0.00
-13.00
100.00%
Consolidate Net Profit
828.00
551.00
50.27%
Operating Profit Margin (Excl OI)
63.40%
12.50%
5.09%
USD in Million.
Net Sales
Not Applicable: The company has declared_date for only one period
Consolidated Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Consolidated) - Nov'25
Nov'25
Nov'24
Change(%)
Net Sales
62,744.00
57,993.40
8.19%
Operating Profit (PBDIT) excl Other Income
5,446.00
5,402.90
0.80%
Interest
220.00
88.60
148.31%
Exceptional Items
-279.00
-4,525.70
93.84%
Consolidate Net Profit
2,179.00
-2,538.00
185.86%
Operating Profit Margin (Excl OI)
48.10%
48.60%
-0.05%
USD in Million.
Net Sales
YoY Growth in year ended Nov 2025 is 8.19% vs 11.56% in Nov 2024
Consolidated Net Profit
YoY Growth in year ended Nov 2025 is 185.86% vs -320.06% in Nov 2024
About Astena Holdings Co., Ltd. 
Astena Holdings Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






